Prescient Therapeutics Limited (PTX.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 10.89 Million AUD | 10.27% |
| 2023 | 9.88 Million AUD | 39.25% |
| 2022 | 7.09 Million AUD | 30.8% |
| 2021 | 5.42 Million AUD | 20.77% |
| 2020 | 4.49 Million AUD | -18.95% |
| 2019 | 5.54 Million AUD | 53.8% |
| 2018 | 3.6 Million AUD | -4.19% |
| 2017 | 3.76 Million AUD | 36.48% |
| 2016 | 2.75 Million AUD | 15.61% |
| 2015 | 2.38 Million AUD | 157.82% |
| 2014 | 924.85 Thousand AUD | 103.23% |
| 2013 | 455.08 Thousand AUD | -76.88% |
| 2012 | 1.96 Million AUD | -5.08% |
| 2011 | 2.07 Million AUD | -1.24% |
| 2010 | 2.1 Million AUD | 5.95% |
| 2009 | 1.98 Million AUD | -31.06% |
| 2008 | 2.87 Million AUD | -54.47% |
| 2007 | 6.31 Million AUD | 26.15% |
| 2006 | 5 Million AUD | -10.67% |
| 2005 | 5.6 Million AUD | 33.33% |
| 2004 | 4.2 Million AUD | 21.69% |
| 2003 | 3.45 Million AUD | 8.38% |
| 2002 | 3.18 Million AUD | 6.04% |
| 2001 | 3 Million AUD | 224.4% |
| 2000 | -2.41 Million AUD | 15.23% |
| 1999 | -2.84 Million AUD | -176.32% |
| 1998 | -1.03 Million AUD | 21.1% |
| 1997 | -1.3 Million AUD | -1432.82% |
| 1996 | 98.08 Thousand AUD | 476.95% |
| 1995 | 17 Thousand AUD | 101.41% |
| 1994 | -1.2 Million AUD | -1182.98% |
| 1993 | -94 Thousand AUD | -202.17% |
| 1992 | 92 Thousand AUD | -54.46% |
| 1991 | 202 Thousand AUD | -71.55% |
| 1990 | 710 Thousand AUD | 498.88% |
| 1989 | -178 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 10.89 Million AUD | 10.26% |
| 2024 Q4 | 4.97 Million AUD | 0.0% |
| 2024 Q2 | 5.92 Million AUD | 0.0% |
| 2023 Q2 | 4.27 Million AUD | 0.0% |
| 2023 FY | 9.88 Million AUD | 39.25% |
| 2023 Q4 | 5.61 Million AUD | 0.0% |
| 2022 FY | 7.09 Million AUD | 30.8% |
| 2022 Q4 | 3.6 Million AUD | 0.0% |
| 2022 Q2 | 3.49 Million AUD | 0.0% |
| 2021 Q4 | 2.97 Million AUD | 0.0% |
| 2021 FY | 5.42 Million AUD | 20.77% |
| 2021 Q2 | 2.45 Million AUD | 0.0% |
| 2020 Q4 | 2.16 Million AUD | 0.0% |
| 2020 FY | 4.49 Million AUD | -18.95% |
| 2020 Q2 | 2.33 Million AUD | 0.0% |
| 2019 FY | 5.54 Million AUD | 53.8% |
| 2019 Q4 | 3.18 Million AUD | 0.0% |
| 2019 Q2 | 2.34 Million AUD | 0.0% |
| 2018 Q2 | 1.63 Million AUD | 0.0% |
| 2018 Q4 | 1.99 Million AUD | 0.0% |
| 2018 FY | 3.6 Million AUD | -4.19% |
| 2017 Q4 | 2.2 Million AUD | 0.0% |
| 2017 FY | 3.76 Million AUD | 36.48% |
| 2017 Q2 | 1.58 Million AUD | 0.0% |
| 2016 Q4 | 1.42 Million AUD | 0.0% |
| 2016 Q2 | 1.33 Million AUD | 0.0% |
| 2016 FY | 2.75 Million AUD | 15.61% |
| 2015 Q4 | 1.29 Million AUD | 0.0% |
| 2015 FY | 2.38 Million AUD | 157.82% |
| 2015 Q2 | 1.09 Million AUD | 0.0% |
| 2014 Q4 | 591.38 Thousand AUD | 0.0% |
| 2014 Q2 | 1.18 Million AUD | 0.0% |
| 2014 FY | 924.85 Thousand AUD | 103.23% |
| 2013 Q4 | 4380.00 AUD | 0.0% |
| 2013 Q3 | 4380.00 AUD | -99.75% |
| 2013 FY | 455.08 Thousand AUD | -76.88% |
| 2013 Q2 | 1.78 Million AUD | 732.53% |
| 2013 Q1 | 214.64 Thousand AUD | 0.0% |
| 2012 Q1 | 156.7 Thousand AUD | 0.0% |
| 2012 FY | 1.96 Million AUD | -5.08% |
| 2012 Q4 | 214.64 Thousand AUD | 0.0% |
| 2012 Q3 | 214.64 Thousand AUD | 0.0% |
| 2012 Q2 | 214.64 Thousand AUD | 36.97% |
| 2011 Q4 | 156.7 Thousand AUD | 0.0% |
| 2011 Q3 | 156.7 Thousand AUD | 0.0% |
| 2011 Q2 | 156.7 Thousand AUD | 29.35% |
| 2011 Q1 | 121.14 Thousand AUD | 0.0% |
| 2011 FY | 2.07 Million AUD | -1.24% |
| 2010 Q1 | 116.3 Thousand AUD | 0.0% |
| 2010 Q4 | 121.14 Thousand AUD | 0.0% |
| 2010 FY | 2.1 Million AUD | 5.95% |
| 2010 Q3 | 121.14 Thousand AUD | 0.0% |
| 2010 Q2 | 121.14 Thousand AUD | 4.17% |
| 2009 Q2 | 116.3 Thousand AUD | -30.07% |
| 2009 Q4 | 116.3 Thousand AUD | 0.0% |
| 2009 Q1 | 166.32 Thousand AUD | 0.0% |
| 2009 FY | 1.98 Million AUD | -31.06% |
| 2009 Q3 | 116.3 Thousand AUD | 0.0% |
| 2008 Q4 | 166.32 Thousand AUD | 0.0% |
| 2008 Q1 | 465.37 Thousand AUD | 0.0% |
| 2008 FY | 2.87 Million AUD | -54.47% |
| 2008 Q2 | 166.32 Thousand AUD | -64.26% |
| 2008 Q3 | 166.32 Thousand AUD | 0.0% |
| 2007 Q1 | 435.69 Thousand AUD | 0.0% |
| 2007 Q3 | 465.37 Thousand AUD | 0.0% |
| 2007 FY | 6.31 Million AUD | 26.15% |
| 2007 Q4 | 465.37 Thousand AUD | 0.0% |
| 2007 Q2 | 465.37 Thousand AUD | 6.81% |
| 2006 FY | 5 Million AUD | -10.67% |
| 2006 Q2 | 435.69 Thousand AUD | -29.78% |
| 2006 Q3 | 435.69 Thousand AUD | 0.0% |
| 2006 Q1 | 620.47 Thousand AUD | 0.0% |
| 2006 Q4 | 435.69 Thousand AUD | 0.0% |
| 2005 FY | 5.6 Million AUD | 33.33% |
| 2005 Q1 | 143.56 Thousand AUD | 0.0% |
| 2005 Q4 | 620.47 Thousand AUD | 0.0% |
| 2005 Q3 | 620.47 Thousand AUD | 0.0% |
| 2005 Q2 | 620.47 Thousand AUD | 332.2% |
| 2004 Q3 | 143.56 Thousand AUD | 0.0% |
| 2004 Q2 | 143.56 Thousand AUD | -65.91% |
| 2004 FY | 4.2 Million AUD | 21.69% |
| 2004 Q1 | 421.07 Thousand AUD | 0.0% |
| 2004 Q4 | 143.56 Thousand AUD | 0.0% |
| 2003 FY | 3.45 Million AUD | 8.38% |
| 2003 Q3 | 421.07 Thousand AUD | 0.0% |
| 2003 Q4 | 421.07 Thousand AUD | 0.0% |
| 2003 Q2 | 421.07 Thousand AUD | -53.49% |
| 2003 Q1 | 905.27 Thousand AUD | 0.0% |
| 2002 Q2 | 905.27 Thousand AUD | 220.48% |
| 2002 Q3 | 905.27 Thousand AUD | 0.0% |
| 2002 Q4 | 905.27 Thousand AUD | 0.0% |
| 2002 FY | 3.18 Million AUD | 6.04% |
| 2002 Q1 | -751.37 Thousand AUD | 0.0% |
| 2001 Q2 | -751.37 Thousand AUD | 34.11% |
| 2001 FY | 3 Million AUD | 224.4% |
| 2001 Q4 | -751.37 Thousand AUD | 0.0% |
| 2001 Q1 | -1.14 Million AUD | 0.0% |
| 2001 Q3 | -751.37 Thousand AUD | 0.0% |
| 2000 Q3 | -1.14 Million AUD | 0.0% |
| 2000 FY | -2.41 Million AUD | 15.23% |
| 2000 Q1 | -712.49 Thousand AUD | 0.0% |
| 2000 Q2 | -1.14 Million AUD | -60.06% |
| 2000 Q4 | -1.14 Million AUD | 0.0% |
| 1999 FY | -2.84 Million AUD | -176.32% |
| 1999 Q1 | -257.85 Thousand AUD | 0.0% |
| 1999 Q2 | -712.49 Thousand AUD | -176.32% |
| 1999 Q4 | -712.49 Thousand AUD | 0.0% |
| 1999 Q3 | -712.49 Thousand AUD | 0.0% |
| 1998 FY | -1.03 Million AUD | 21.1% |
| 1998 Q4 | -257.85 Thousand AUD | 0.0% |
| 1998 Q3 | -257.85 Thousand AUD | 0.0% |
| 1998 Q2 | -257.85 Thousand AUD | 21.1% |
| 1998 Q1 | -326.81 Thousand AUD | 0.0% |
| 1997 Q2 | -326.81 Thousand AUD | -1432.85% |
| 1997 FY | -1.3 Million AUD | -1432.82% |
| 1997 Q3 | -326.81 Thousand AUD | 0.0% |
| 1997 Q1 | 24.52 Thousand AUD | 0.0% |
| 1997 Q4 | -326.81 Thousand AUD | 0.0% |
| 1996 FY | 98.08 Thousand AUD | 476.95% |
| 1996 Q4 | 24.52 Thousand AUD | 0.0% |
| 1996 Q3 | 24.52 Thousand AUD | 0.0% |
| 1996 Q2 | 24.52 Thousand AUD | 476.94% |
| 1996 Q1 | 4250.00 AUD | 0.0% |
| 1995 FY | 17 Thousand AUD | 101.41% |
| 1995 Q4 | 4250.00 AUD | 0.0% |
| 1995 Q3 | 4250.00 AUD | 0.0% |
| 1995 Q2 | 4250.00 AUD | 101.41% |
| 1995 Q1 | -301.5 Thousand AUD | 0.0% |
| 1994 Q1 | -23.5 Thousand AUD | 0.0% |
| 1994 FY | -1.2 Million AUD | -1182.98% |
| 1994 Q4 | -301.5 Thousand AUD | 0.0% |
| 1994 Q3 | -301.5 Thousand AUD | 0.0% |
| 1994 Q2 | -301.5 Thousand AUD | -1182.98% |
| 1993 Q3 | -23.5 Thousand AUD | 0.0% |
| 1993 Q2 | -23.5 Thousand AUD | -232.39% |
| 1993 Q1 | 17.75 Thousand AUD | 0.0% |
| 1993 Q4 | -23.5 Thousand AUD | 0.0% |
| 1993 FY | -94 Thousand AUD | -202.17% |
| 1992 Q3 | 17.75 Thousand AUD | 0.0% |
| 1992 Q4 | 17.75 Thousand AUD | 0.0% |
| 1992 FY | 92 Thousand AUD | -54.46% |
| 1992 Q1 | -4500.00 AUD | 0.0% |
| 1992 Q2 | 17.75 Thousand AUD | 494.44% |
| 1991 Q4 | -4500.00 AUD | 0.0% |
| 1991 Q3 | -4500.00 AUD | 0.0% |
| 1991 FY | 202 Thousand AUD | -71.55% |
| 1991 Q2 | -4500.00 AUD | -101.98% |
| 1991 Q1 | 227.5 Thousand AUD | 0.0% |
| 1990 Q2 | 227.5 Thousand AUD | 437.04% |
| 1990 Q4 | 227.5 Thousand AUD | 0.0% |
| 1990 Q3 | 227.5 Thousand AUD | 0.0% |
| 1990 Q1 | -67.5 Thousand AUD | 0.0% |
| 1990 FY | 710 Thousand AUD | 498.88% |
| 1989 Q3 | -67.5 Thousand AUD | 0.0% |
| 1989 FY | -178 Thousand AUD | 0.0% |
| 1989 Q4 | -67.5 Thousand AUD | 0.0% |
| 1989 Q2 | -67.5 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AdAlta Limited | 6.76 Million AUD | -60.998% |
| Acrux Limited | 8.55 Million AUD | -27.471% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -29.198% |
| Biome Australia Limited | 7.91 Million AUD | -37.764% |
| BTC Health Limited | -1.03 Million AUD | 1149.042% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | 44.865% |
| CSL Limited | 7.56 Billion AUD | 99.856% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 80.644% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 65.176% |
| Noxopharm Limited | 7 Million AUD | -55.693% |
| PharmAust Limited | 6.65 Million AUD | -63.719% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -1121.641% |
| PYC Therapeutics Limited | 60.91 Million AUD | 82.109% |
| Race Oncology Limited | 14.77 Million AUD | 26.212% |
| Starpharma Holdings Limited | 22.81 Million AUD | 52.232% |
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 72.46% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -1710.97% |
| Memphasys Limited | 3.67 Million AUD | -196.293% |
| Nyrada Inc. | 4.55 Million AUD | -139.262% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -1434.571% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 95.952% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -294.738% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -83.219% |
| Patrys Limited | 4.93 Million AUD | -120.922% |
| Dimerix Limited | 25.64 Million AUD | 57.498% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 66.667% |
| Orthocell Limited | 15.36 Million AUD | 29.088% |
| Imugene Limited | 135.09 Million AUD | 91.932% |
| Cynata Therapeutics Limited | 11.12 Million AUD | 2.021% |
| Immutep Limited | 42.87 Million AUD | 74.58% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -1.052% |
| Alterity Therapeutics Limited | 23.4 Million AUD | 53.437% |
| Nanollose Limited | 12.5 Thousand AUD | -87083.281% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -225.737% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -454.583% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -164.19% |
| Biotron Limited | 5.11 Million AUD | -113.255% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -3542.3% |
| Tissue Repair Ltd | 6.66 Million AUD | -63.478% |
| AnteoTech Limited | 12.18 Million AUD | 10.57% |
| Hexima Limited | 1 Million AUD | -980.424% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 83.259% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | 49.739% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -139.776% |
| Actinogen Medical Limited | 22.77 Million AUD | 52.136% |
| Immuron Limited | 9.13 Million AUD | -19.27% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -31.801% |